EGFR and glioblastoma: Similar observations were made recently in the case of glioblastomas carrying activated EGFR and Met receptors where simultaneous inhibition of EGFR (erlotinib) and Met (SU11274) lead to the downregulation of PI3K pathway, and reduced the size of colony formation in soft agar (Stommel et al, 2007).